The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients—A Systematic Review
Open accessThe DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
Treatment of older patients with benzodiazepines and Z-drugs (BZRA) is associated with an increased risk of side effects. However, this treatment is still used among these patients. Deprescribing can be a tool to reduce inappropriate medication. This review aims to identify and compare barriers and facilitators of stakeholders involved in BZRA deprescribing in older patients and uncover potential gaps in the research field. The search was conducted in PubMed, EMBASE, PsycINFO, and Cochrane Library. Ten articles based on qualitative data on BZRA deprescribing in older patients (≥65 years) published between 2005–2020 were included. Six articles referred to patients as stakeholders, two referred to physicians, and one to nurses and caregivers, respectively, indicating a need for more studies in the field. More barriers than facilitators were identified. Important findings were the patient willingness to deprescribe BZRA compared to physicians, who did not mention deprescribing to patients due to barriers such as expected patient resistance. Nurses mentioned barriers like lack of knowledge and the feeling that their options were not valued by physicians; education was found to be a shared deprescribing facilitator among the stakeholders. Being aware of deprescribing barriers and facilitators can be helpful in future successful deprescribing interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fragmented care can be a barrier to effective BZD tapering because attitudes, knowledge, and conflicting advice from a patient’s medical teams (e.g., primary care, psychiatry, neurology, other specialty clinicians) and care partners can influence the BZD tapering process.92,169,170”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [170]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tong, A., Sainsbury, P., & Craig, J. (2007) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzm042 · Cited by 42,509
By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15767 · Cited by 3,163
Reducing Inappropriate Polypharmacy: The Process of Deprescribing
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C. B., Roughead, E. E., Page, A., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,584
Robson, C., & McCartan, K. (2016) · UWE Research Repository (UWE Bristol) · Cited by 1,320
Tannenbaum, C., Martin, P., Tamblyn, R., Benedetti, A., & Ahmed, S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.949 · Cited by 665 · cited 3×
“Some physicians felt that deprescribing lead to unnecessary suffering for the patients [20], which was shared with the patients who expressed concern about withdrawal symptoms [8,17,18,20].”
BackgroundMethodDeveloping the Review Question and Inclusion Criteria
Stern, C., Jordan, Z., & McArthur, A. (2014) · AJN, American Journal of Nursing · doi:10.1097/01.naj.0000445689.67800.86 · Cited by 629
Reeve, E., Shakib, S., Hendrix, I., Roberts, M. S., & Wiese, M. D. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12386 · Cited by 388
Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline.
(2018) · Europe PMC (PubMed Central) · Cited by 250
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
Physicians’ perspectives on prescribing benzodiazepines for older adults: a qualitative study
Cook, J. M., Marshall, R., Masci, C., & Coyne, J. C. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0021-3 · Cited by 178 · cited 10×
“Ageism: Finding deprescribing BZRA as unnecessary due the age of the patient 3 * [8,16,17] 2 [20] No data”
BackgroundInfluential
Cited by
Capiau, A., Huys, L., van Poelgeest, E. P., van der Velde, N., Petrović, M., Somers, A., & the EuGMS Task, F. G. O. F. (2022) · European Geriatric Medicine · doi:10.1007/s41999-022-00731-4 · Cited by 94
Evrard, P., Pétein, C., Beuscart, J.-B., & Spinewine, A. (2022) · Implementation Science · doi:10.1186/s13012-022-01206-7 · Cited by 62
Brunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09499-2 · Cited by 51
“92,169,170 Although this situation may exist for any patients with multiple health-care providers, it is particularly common among older adults.”
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.
Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02445-4 · Cited by 51
Zeraatkar, D., Nagraj, S. K., Ling, M., Jassal, T., Kirsh, S., Lima, J. P., Pitre, T., Couban, R., Hussain, M., Seterelv, S. S., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081336 · Cited by 30
Metadata
- Authors
- Rasmussen, A. F., Poulsen, S. S., Oldenburg, L. I. K., & Vermehren, C.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Vermehren, Charlotte
- Venue
- Metabolites
- Publisher
- MDPI AG
- Published
- 2021-04-20
- Volume
- 11
- Issue
- 4
- Pages
- 254
- ISSN
- 2218-1989 (ISSN-L)
- PMC
- PMC8073998
- OpenAlex
- W3154125531
- Cited by
- 39
- References
- 26
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 16 · 2023: 1 · 2022: 6 · 2021: 2
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Metabolites (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Region Hovedstaden
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- deprescribing, benzodiazepine receptor agonists, Z-drugs, older adults, barriers and facilitators, stakeholder perspectives, physician-patient communication, nurses' knowledge, inappropriate medication use, polypharmacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients—A Systematic Review. https://app.cochat.ai/papers/10.3390/metabo11040254
- The paper
- Rasmussen, A. F., Poulsen, S. S., Oldenburg, L. I. K., & Vermehren, C. (2021). The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients—A Systematic Review. Metabolites. https://doi.org/10.3390/metabo11040254
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
